King Wang (Nan) LI

Nan Li is a managing partner of Tian Yuan Law Firm and the head of the Hong Kong office. 

Mr. Li has focused on public and private securities offerings, cross border mergers and acquisitions and private equity investments during his years of practice. Mr. Li is honored as an elite lawyer in The A List China by China Business Law Journal for his outstanding performance and has been awarded as the Top 100 International Lawyers with China-related practices for consecutive years, and is recognized as a leading capital markets lawyer by The Legal 500 and IFLR 1000. He has led Tian Yuan Hong Kong practice to gain an excellent reputation in providing legal services for overseas IPO projects of Chinese companies in the New Economy related industry sectors. Mr. Li was regarded as “expert in finance and mergers and acquisitions” and was praised by the client to be “proficient in foreign and Chinese law, and has a deep understanding of customer business”, is “a lawyer of sound judgment and great diligence and carefulness”, “able to creatively provide solutions for customers”, and “able to find the best solutions based on professional experience and the company’s actual problems”.  Prior to joining Tian Yuan, Mr. Li was a global partner and the chief representative of Beijing office of an international law firm.

• In terms of Red Chips listing, Mr. Li has successfully advised the listing of Gaush Meditech Ltd, Zibuyu Group Limited, Howkingtech International Holding Limited, GUSHENGTANG HOLDINGS LIMITED, Chaoju Eye Care Holdings Limited, Hygeia Healthcare Holdings Co., Limited, Simcere Pharmaceutical Group Limited, Strawbear Entertainment Group, Neusoft Education Technology Co. Limited, Netjoy Holdings Limited, Jinxin Fertility Group Limited, Ascletis Pharma Inc., New Century Healthcare Holding Co. Limited, Harmonicare Medical Holdings Limited, MicroPort Scientific Corporation, Weimob Inc., Midea Real Estate Holding Limited, DaFa Properties Group Limited, Optics Valley Union Holding Company Limited, Zhou Hei Ya International Holdings Company Limited, Yihai International Holding Ltd., Yadea Group Holdings Ltd., Honma Golf Limited, Koradior Holdings Limited, China Agri-Industries Holdings Limited, Tenwow International Holdings Limited, China Yongda Automobiles Services Holdings Limited, Fosun Tourism Group, China Huirong Financial Holdings Limited, Chinalco Mining Corporation International, Dameng Mining Industries Ltd. and China Resources Cement Holdings Limited.
• In terms of H Share listing, Mr. Li has successfully advised the listing of CanSino Biologics Inc., Chanjet Information Technology Company Limited, Livzon Pharmaceutical Group Inc., Bank of Gansu Co., Ltd., Bank of Tianjin Co., Ltd., Zhongyuan Bank Co., Ltd., Holly Futures Co., Ltd., Guangzhou Automobile Group Co., Ltd., China International Marine Containers (Group) Co., Ltd., China Coal Holdings Limited, Huadian Fuxin Energy Corporation Limited, Metallurgical Corporation of China Ltd., China Communications Construction Company Limited and China Coal Energy Company Limited.
• Represented Hygeia Healthcare Holdings Co., Limited in its RMB1.73 billion acquisition of the entire equity interest in Etern Group Ltd.
• Represented Hygeia Healthcare Holdings Co., Limited in its up to RMB642 million acquisition of 99% equity interest in Hezhou Guangji Hospital Co., Ltd. from GF Xinde (Zhuhai) Medical Industrial Investment Center L.P.
• Represented Beijing Chuangxinzhong Technology Co., Ltd. in the acquisition of its 42.5% equity interest by YEAHKA LIMITED.

• Capital markets: Equity
• M&A
• Private equity

• Automotive
• Consumer goods and services
• Healthcare
• Media
• Technology and telecommunications

• LL.M. University of Pennsylvania Law School
• LL.B. China University of Political Science and Law